90 related articles for article (PubMed ID: 3958969)
1. Effects of hydralazine on streptozotocin-induced diabetic rats: prevention of hyperlipidemia and improvement in cardiac function.
Rodrigues B; Goyal RK; McNeill JH
J Pharmacol Exp Ther; 1986 Apr; 237(1):292-9. PubMed ID: 3958969
[TBL] [Abstract][Full Text] [Related]
2. Effects of hydralazine on cardiac responsiveness to adrenergic agonists in streptozotocin-induced diabetic rats.
Goyal RK
Indian J Physiol Pharmacol; 1993 Oct; 37(4):285-90. PubMed ID: 7906674
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of atenolol and metoprolol on cardiovascular complications associated with streptozotocin-induced diabetic rats.
Bhadada SV; Goyal RK
Can J Physiol Pharmacol; 2007 Aug; 85(8):831-6. PubMed ID: 17901894
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats.
Hakim ZS; Patel BK; Goyal RK
Indian J Physiol Pharmacol; 1997 Oct; 41(4):353-60. PubMed ID: 10235657
[TBL] [Abstract][Full Text] [Related]
5. Investigation into the cardiac effects of spironolactone in the experimental model of type 1 diabetes.
Goyal BR; Solanki N; Goyal RK; Mehta AA
J Cardiovasc Pharmacol; 2009 Dec; 54(6):502-9. PubMed ID: 19738487
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
Hakim ZS; Goyal RK
Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
[TBL] [Abstract][Full Text] [Related]
7. Effect of hypertension on the development of diabetic cardiomyopathy.
Mathis DR; Liu SS; Rodrigues BB; McNeill JH
Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979
[TBL] [Abstract][Full Text] [Related]
8. Effects of brain natriuretic peptide on contraction and intracellular Ca2+ in ventricular myocytes from the streptozotocin-induced diabetic rat.
Howarth FC; Al-Shamsi N; Al-Qaydi M; Al-Mazrouei M; Qureshi A; Chandranath SI; Kazzam E; Adem A
Ann N Y Acad Sci; 2006 Nov; 1084():155-65. PubMed ID: 17151299
[TBL] [Abstract][Full Text] [Related]
9. Effect of hydralazine on myocardial plasma membrane fatty acid binding protein (PM-FABP) during diabetes mellitus.
Heyliger CE; Powell DM; Skau KA
Mol Cell Biochem; 1995 Jul; 148(1):39-44. PubMed ID: 7476932
[TBL] [Abstract][Full Text] [Related]
10. Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.
Udayachalerm W; Vechakarn O; Patumraj S
J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S306-13. PubMed ID: 11529349
[TBL] [Abstract][Full Text] [Related]
11. Effect of chronic treatment with losartan on streptozotocin induced diabetic rats.
Murali B; Goyal RK
Indian J Exp Biol; 2002 Jan; 40(1):31-4. PubMed ID: 12561964
[TBL] [Abstract][Full Text] [Related]
12. Working heart function in diabetes is not improved by spironolactone treatment.
Verma S; Yuen VG; Badiwala M; Anderson TJ; McNeill JH
Can J Physiol Pharmacol; 2003 May; 81(5):493-6. PubMed ID: 12774856
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.
Majithiya JB; Paramar AN; Balaraman R
Cardiovasc Res; 2005 Apr; 66(1):150-61. PubMed ID: 15769458
[TBL] [Abstract][Full Text] [Related]
14. IGF-I attenuates diabetes-induced cardiac contractile dysfunction in ventricular myocytes.
Norby FL; Wold LE; Duan J; Hintz KK; Ren J
Am J Physiol Endocrinol Metab; 2002 Oct; 283(4):E658-66. PubMed ID: 12217882
[TBL] [Abstract][Full Text] [Related]
15. Short-term effects of streptozotocin-induced diabetes on the electrocardiogram, physical activity and body temperature in rats.
Howarth FC; Jacobson M; Naseer O; Adeghate E
Exp Physiol; 2005 Mar; 90(2):237-45. PubMed ID: 15640274
[TBL] [Abstract][Full Text] [Related]
16. Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat.
Howarth FC; Jacobson M; Shafiullah M; Adeghate E
Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):327-31. PubMed ID: 16620296
[TBL] [Abstract][Full Text] [Related]
17. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.
Koçak G; Aktan F; Canbolat O; Ozoğul C; Elbeğ S; Yildizoglu-Ari N; Karasu C;
Diabetes Nutr Metab; 2000 Dec; 13(6):308-18. PubMed ID: 11232755
[TBL] [Abstract][Full Text] [Related]
18. Metformin treatment restores the altered microvascular reactivity in neonatal streptozotocin-induced diabetic rats increasing NOS activity, but not NOS expression.
Sartoretto JL; Melo GA; Carvalho MH; Nigro D; Passaglia RT; Scavone C; Cuman RK; Fortes ZB
Life Sci; 2005 Oct; 77(21):2676-89. PubMed ID: 15964597
[TBL] [Abstract][Full Text] [Related]
19. Cod liver oil supplementation improves cardiovascular and metabolic abnormalities in streptozotocin diabetic rats.
Ceylan-Isik A; Hünkar T; Aşan E; Kaymaz F; Ari N; Söylemezoğlu T; Renda N; Soncul H; Bali M; Karasu C;
J Pharm Pharmacol; 2007 Dec; 59(12):1629-41. PubMed ID: 18053324
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
Sevak AR; Goyal RK
Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
